Key points are not available for this paper at this time.
Introduction 7%, 59 with A1C ≥7- ≤ 8%, 30 with A1C 8- ≤ 9%, and 42 persons with A1C 9% respectively. There were 1,131 initial interventions made in relation to their diabetes and cardiovascular medications/supplies, immunization, preventative medication, laboratory and referral recommendations. In the final outcome analysis, 208 persons were included due to continued active engagement in the program. The mean change in weight from baseline was found to be -1.75 kg (-1.73%) and the mean change in A1C from baseline was -0.94 (-9.71%). Conclusion: Our employee diabetes program showed a trend toward improved persons with diabetes outcomes with active engagement up to one year. The waived copay financial incentive related to diabetes medications and supplies motivated follow-up engagement and numerically lead to a reduction in weight and A1C values. Further examination is planned for new and those with continued enrollment. Disclosure H.A. Habib: None. N. Saad: None. L. Hughes: Advisory Panel; embecta.
HABIB et al. (Fri,) studied this question.